Buscar
Mostrando ítems 1-10 de 41
Polycystic ovary syndrome: clinical and laboratory evaluation
(Associação Paulista de Medicina - APM, 1996-08-01)
OBJECTIVE: To evaluate clinically, and with laboratory, tests, women with polycystic ovary syndrome (PCO). PATIENTS: One hundred and twelve women with PCO were studied. METHODS: The following data was recorded: Current ...
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
(Taylor & Francis, 2015)
We evaluated the association of hirsutism and oligomenorrhea (persistent menstrual cycles > 45
days) as screening criteria for the detection of biochemical hyperandrogenism (BH) and polycystic
ovaries (PCOM) during ...
Uso de la metformina en pacientes con el síndrome del ovario poliquístico
(Colegio de Médicos y Cirujanos de Costa Rica, 2007)
Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus
(ELSEVIER, 2010-10)
Objective: To evaluate the prevalence and risk factors of menstrual cycle irregularities in adolescents with type 1
diabetes mellitus.
Design: Prospective diary of menstrual cycle.
Setting: Pediatric diabetes clinics ...
Hirsutismo autorreportado e comorbidades na pós-menopausa
(Universidade Federal de Santa MariaBrasilCiências da SaúdeUFSMPrograma de Pós-Graduação em Ciências da SaúdeCentro de Ciências da Saúde, 2017-01-13)
Polycystic Ovarian Syndrome (PCOS) is the most frequent metabolic disorder in the female
population. It affects 10% of women of childbearing age, and its pathophysiology, although not
completely known, is associated with ...
Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervals
(1974)
A new contraceptive compound, R-2323, was tried as a "weekly pill". The pregnancy rate at 12 months was 3.7 considering only method failures. The most important ill effect was alterations in bleeding patterns, with a ...